flstandardbreds Chapter 418 They are all the same.
Chapter 418 They are all the same.
……
After everyone accepted the news, Chen Xuan spoke again, "If you are interested in this drug, you can pay attention to the upcoming clinical trials. We will disclose the entire clinical trial process in real time."
Shengyuan medicine is different from restoring eye drops.
The effect of the eye drops is immediate and everyone can see the results directly.
But it is different for bio-sourced drugs. Their indications are all various chronic diseases, so there is no way to display them directly.
You can't find a gout patient on the spot and ask him to try the biosource medicine to demonstrate the treatment effect. There is no point in doing so.
Therefore, Chen Xuan did not prepare any trial sessions, but simply introduced the indications and displayed some test data.
However, the range of indications of Shengyuan Medicine also left everyone stunned.
This new drug has too many indications, and they are all common diseases with very high prevalence rates, belonging to a very large group of people.
Simply put, the market for biogenic drugs is likely to be a market of more than 10 billion people, or even a huge market of far more than 10 billion people.
It is indeed incredible that just one drug can cover such an amazing group of patients, but it also shows the huge potential.
"Chen Xuan is so awesome."
"Hiss, if these effects can be realized, then this market will be amazing."
"Mr. Chen never makes false claims or exaggerates, and its effectiveness is often better than advertised."
"That's right. As long as Mr. Chen says it himself, you can rest assured."
"This drug still needs clinical trials. We'll know whether it's effective or not then. You don't have to worry. Just wait and see the results of the clinical trials."
"The market potential for biogenic drugs is huge. I think it's no less than that for restoring vision eye drops."
"I suddenly understand why Mr. Chen said Antai Pharmaceutical Group is worth $4000 billion. It's really worth that much, and there's no exaggeration at all."
Although most of the people present were laymen, they could also see the market for bio-sourced medicines.
If this therapeutic effect can be achieved, then this medicine will definitely become a monopoly.
At this time, everyone completely understood what Chen Xuan had said before about the valuation of Antai Pharmaceutical Group.
Before, people thought it was exaggerated and that $4000 billion was unrealistic, but after the two drugs were unveiled one after another, everything seemed so reasonable.
"Both new drug applications for clinical trials have been approved."
"From today, clinical trials will officially begin, and clinical trials will be conducted for various indications."
"By then, all the results of the clinical trials will be made public in real time. If you are interested, you can keep an eye on them and you are welcome to raise questions."
Chen Xuan spoke again, "I'm very happy that everyone is supervising new drugs and raising reasonable questions. This is the only way to ensure the safety of new drugs and make them better."
Having said that, it also means that the new drug introduction session has come to an end.
But at the end, he did not forget to imply something about Amit.
He can accept reasonable supervision and questioning, but not the same groundless questioning as the latter.
"Mr. Chen!"
"The Phase III clinical trials of the pancreatic cancer drug and the self-love drug have both been successfully completed, and the clinical performance has exceeded expectations."
"Will these two new drugs be launched soon? Has your group planned the launch date for these two drugs?"
At this time, Bingbing raised these two questions in a timely manner.
Although both biogenic medicine and restoring eye drops are important, they are also medical achievements that shocked the world.
But the most urgent task is to find effective drugs for pancreatic cancer and self-love drugs.
After all, the first two drugs have just been developed and even the first phase of clinical trials has not yet begun. It will definitely take a long time for them to be truly launched on the market.
The latter two drugs are different. Their phase III clinical trials have been declared successful and their launch is imminent.
Countless people are waiting for these two life-saving drugs.
"The clinical trials of our pancreatic cancer-specific drug and self-love drug have been a complete success. We have obtained marketing approval in China and several other countries, and they will be available for sale at any time."
"However, regarding the specific launch date, our group is still discussing it, mainly through communication with the pharmacies of major hospitals, but it will basically be this month."
Faced with this question, Chen Xuan also gave a positive answer.
Antai Pharmaceutical Group also attaches great importance to the launch time of pancreatic cancer specific drugs and self-love drugs.
After all, these two drugs are products that can make money as soon as they are put into use. If you buy them in the morning, you can make more money every day, and it is basically a sure profit.
Judging from the market demand for the two drugs, their profits may be greater than those of lung cancer drugs once they are launched on the market. In this case, Antai Pharmaceutical Group will naturally have more motivation to push for an early launch.
It’s just that medicines are different from ordinary commodities, especially new drugs, which require extreme caution.
Therefore, every link must be taken seriously, which means more time is needed for preparation and review, and it is impossible to go public casually.
But even so, it is time for these two drugs to be officially launched on the market.
When they got Chen Xuan's positive answer, everyone cheered.
For many people, this news is indeed more exciting than the Chinese New Year.
"Mr. Chen, I'm really happy to hear this good news."
"But regarding the market pricing of pancreatic cancer-specific drugs and self-care drugs, could you please disclose it now? This is also an issue that many patients and their families are very concerned about."
Bingbing asked again.
This issue is also what concerns countless people the most.
"Regarding the pricing of pancreatic cancer drugs, the domestic drug pricing is basically the same as that of lung cancer drugs."
"At the same time, the pancreatic cancer drug will also be included in the Chinese medical insurance catalog. Just like the lung cancer drug, the price and distribution channels will be the same."
Looking at everyone's expectant eyes, Chen Xuan smiled and spoke directly.
Things like this will be made public sooner or later, there is no need to hide them.
His answer instantly made everyone excited.
There is no doubt that compared with this price, many people feel very satisfied. This is the drug price that best meets their requirements.
The price of this medicine is not cheap, but it gives many people hope of survival.
Especially after it was included in the medical insurance catalogue, many poor people can afford to buy medicine and treat their illnesses.
2000 yuan a month as life-saving money.
For most families, although it is not easy, at least they can afford it.
After all, their previous treatment costs were ten or even dozens of times more than this.
Moreover, although so much extra medical expenses were incurred, the effect was almost negligible.
……